Literature DB >> 18555031

Precautions to be taken by radiologists and radiographers when prescribing hyoscine-N-butylbromide.

R Dyde1, A H Chapman, R Gale, A Mackintosh, D J M Tolan.   

Abstract

Hyoscine-N-butylbromide (Buscopan, Boehringer Ingelheim) is a widely used antispasmodic in radiological practice. There seems to be no consensus as to best practice within radiology regarding the precautions that need to be taken when prescribing Buscopan. We have performed a thorough review of the available literature and make the following recommendations to those administering Buscopan: (1) enquire whether there is an allergic history; (2) ensure patient literature warns that "in the rare event that following the examination you develop painful, blurred vision in one or both eyes, you must attend hospital immediately for assessment"; (3) warn patients to expect blurred vision and not to drive until this has worn off; (4) remind clinicians that special consideration needs to be given as to the method of investigating patients with cardiac instability, such as those recently admitted with acute coronary syndrome, recurrent cardiac pain at rest, uncontrolled left ventricular failure and recent ventricular arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18555031     DOI: 10.1016/j.crad.2008.02.008

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  9 in total

1.  Administration of hyoscine- n-butylbromide during colonoscopy: a survey of current UK practice.

Authors:  Matthew Robert Bedford; Tristan Reuser; Paul Wilson; Sharad Karandikar; Douglas Bowley
Journal:  Frontline Gastroenterol       Date:  2012-06-16

2.  Prostate magnetic resonance imaging at 3 Tesla: Is administration of hyoscine-N-butyl-bromide mandatory?

Authors:  Matthias C Roethke; Timur H Kuru; Alexander Radbruch; Boris Hadaschik; Heinz-Peter Schlemmer
Journal:  World J Radiol       Date:  2013-07-28

3.  Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate.

Authors:  T Ullrich; M Quentin; A K Schmaltz; C Arsov; C Rubbert; D Blondin; R Rabenalt; P Albers; G Antoch; L Schimmöller
Journal:  Eur Radiol       Date:  2017-07-07       Impact factor: 5.315

4.  Value of bowel preparation techniques for prostate MRI: a preliminary study.

Authors:  Cynthia Schmidt; Andreas M Hötker; Urs J Muehlematter; Irene A Burger; Olivio F Donati; Borna K Barth
Journal:  Abdom Radiol (NY)       Date:  2021-03-26

5.  Impact of Hyoscine Bromide Use on Polyp Detection Rate During Colonoscopy: A Systematic Review and Meta-Analysis.

Authors:  Muhammad Yasir Khan; Ahmed Dirweesh; Waqas Javed Siddiqui
Journal:  Gastroenterology Res       Date:  2018-02-08

6.  Multiparametric MRI - local staging of prostate cancer and beyond.

Authors:  Iztok Caglic; Viljem Kovac; Tristan Barrett
Journal:  Radiol Oncol       Date:  2019-05-08       Impact factor: 2.991

7.  Feasibility of Simultaneous Multislice Acceleration Technique in Diffusion-Weighted Magnetic Resonance Imaging of the Rectum.

Authors:  Jae Hyon Park; Nieun Seo; Joon Seok Lim; Jongmoon Hahm; Myeong Jin Kim
Journal:  Korean J Radiol       Date:  2020-01       Impact factor: 3.500

8.  A feasibility study of hyoscine butylbromide (buscopan) to improve image quality of cone beam computed tomography during abdominal/pelvic Stereotactic Ablative Radiotherapy.

Authors:  Finbar Slevin; Matthew Beasley; Jim Zhong; Eleanor Hudson; Richard Speight; John Lilley; Louise J Murray; Ann M Henry
Journal:  BJR Open       Date:  2021-07-29

9.  Temporary diplopia upon hyoscine-N-butyl bromide administration: case report.

Authors:  R Migliorini; R Malagola; M Mafrici; R Spena; L Arrico
Journal:  Clin Ophthalmol       Date:  2013-05-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.